Apple’s flagship iPhones X won’t be available on the market until November—a stark departure from the company’s typical schedule.
Apple’s iPhone X not only carries the same price in dollars as it does in British pounds but also represents the most expensive iPhone ever.
Apple has stuck to its tradition of releasing its new iPhone models in September, but it veered away from a pricing culture that it has practiced for years.
On August 22, 2017, Baxter International entered into a collaboration with ASPEN (American Society for Parenteral and Enteral Nutrition) and launched SmartPN.
On July 27, 2017, Baxter International (BAX) completed the acquisition of Claris Injectables, which is expected to help expand and strengthen Baxter’s core capabilities.
Baxter International (BAX) has updated its sales guidance growth from 2.0%–3.0% to approximately 4.0% on a constant currency basis.
Baxter International (BAX) has been going through a cost transformation and reorganization process for some time. The initiative includes some leadership and management changes.
On August 2, Stryker (SYK) announced a quarterly cash dividend of $0.425 per share. The dividend should be payable on October 31 to shareholders of record on September 29.
As we discussed in the previous part of this series, Stryker received FDA warnings regarding some of its Sage Products.
On August 23, Stryker (SYK) announced a voluntary product recall of specific lots of oral care products that form part of the company’s Sage business unit.
Medtronic (MDT) repurchased a net $1.1 billion of its ordinary shares in fiscal 1Q18.
Medtronics’ MITG (Minimally Invasive Therapies Group) business is expected to grow 3.5%–4.5%.
In January 2015, Medtronic (MDT) acquired Covidien for ~$43 billion in cash and MDT stock in a tax inversion deal.
In fiscal 1Q18, Medtronic’s (MDT) Diabetes Group reported revenues of $449 million, which represents a year-over-year sales decline of ~1%.
On August 22, Medtronic (MDT) recorded $7.4 billion in revenues for fiscal 1Q18, falling short of Wall Street’s estimate of $7.5 billion. In this series, we’ll examine MDT’s outlook for fiscal 2Q18 and fiscal 2018.
Cybersecurity stocks such as Symantec, Cisco Systems, and FireEye (FEYE) received a boost in 1H17 by the WannaCry and NotPetya ransomware attacks.
In its fiscal 1Q18 earnings release, Symantec highlighted that its Website Security and related PKI solutions are expected to contribute ~$400 million and ~$180 million in overall revenues and operating income, respectively.
Blue Coat Systems, which marked Symantec’s largest acquisition in more than a decade, was offloaded by Thoma Bravo to private equity firm Bain Capital in mid-2015.
Symantec purchased its Website Security business from VeriSign in 2010. In 2012, the company bought the remaining interest in VeriSign Japan.
CyberArk (CYBR) and Check Point Software Technologies (CHKP) are among the well-established cybersecurity companies with roots in Israel.